FDA Inspection 1335282 — GRAIL, Inc.
The FDA completed an inspection of GRAIL, Inc. on Aug 31, 2026 in Menlo Park, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 31, 2026
- Fiscal Year
- 2026
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Menlo Park, CA (United States)
Additional Details
Sponsor, Contract Research Organization